Get the Stockscreener App
5.1278
0.94%
0.0478
Pluri Inc stock is traded at $5.1278, with a volume of 22,955.
It is up +0.94% in the last 24 hours and up +29.44% over the past month.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
See More
Previous Close:
$5.08
Open:
$4.94
24h Volume:
22,955
Relative Volume:
0.64
Market Cap:
$40.36M
Revenue:
$598.00K
Net Income/Loss:
$-21.81M
P/E Ratio:
-1.2446
EPS:
-4.12
Net Cash Flow:
$-16.66M
1W Performance:
+2.25%
1M Performance:
+29.44%
6M Performance:
+21.51%
1Y Performance:
-8.43%
1-Day Range:
$4.94
$5.1278
1-Week Range:
$4.5673
$5.52
52-Week Range:
$3.33
$7.13
Pluri Inc Stock (PLUR) Company Profile
Name
Pluri Inc
Sector
Industry
Phone
972-74-710-7171
Address
MATAM ADVANCED TECHNOLOGY PARK, HAIFA
Compare PLUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLUR
Pluri Inc
|
5.1278 | 39.99M | 598.00K | -21.81M | -16.66M | -4.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.06 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.08 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.17 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
570.76 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.29 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Pluri Inc Stock (PLUR) Latest News
Pluri Inc. Stock Analysis and ForecastSpectacular growth rates - jammulinksnews.com
What analysts say about Pluri Inc. stockOver 200% growth - jammulinksnews.com
What drives Pluri Inc. stock priceTremendous financial leverage - jammulinksnews.com
Uno Minda Limited (532539)’s Trend in 2025Record-breaking gains - Autocar Professional
Is Pluri Inc. a good long term investmentAccelerated wealth building - jammulinksnews.com
Is XPEV a good long term investmentTremendous gains - jammulinksnews.com
What analysts say about SPKLW stockDynamic investment growth - jammulinksnews.com
What analysts say about TWST stockAccelerated capital growth - jammulinksnews.com
Is Centuri Holdings Inc. a good long term investmentFree Stock Market Return Analysis - jammulinksnews.com
What makes Pluri Inc. stock attractive to long term investorsBalanced Risk Reward Portfolio - Newser
Stocks to Buy for Long Term Capital Gains in India Elite Investment Community InsightsRobust investment performance - jammulinksnews.com
Achyut Healthcare Limited (543499)’s Trend in 2025Accelerated capital growth - jammulinksnews.com
How high can Pluri Inc. stock price go in 2025Proven Win Setups - Newser
Suraksha Diagnostic Limited (SURAKSHA) Hits 52 Week HighHigh-velocity capital appreciation - jammulinksnews.com
What makes SLM Corporation stock price move sharplyFree AI-Powered Stock Predictions - Newser
Is It Worth Buying INCORGNITO(incorgnito)Risk Controlled Trading Ideas - Newser
What makes Pluri Inc. stock price move sharplyFree Stock Market Return Analysis - Newser
Why Pluri Inc. stock attracts strong analyst attentionLow Risk Trade Timing Signals - Newser
What makes Katapult Holdings Inc. Equity Warrant stock price move sharplyFree Exclusive Access to Stock Gurus - Newser
Why Alpha Tau Medical Ltd. stock attracts strong analyst attentionFree Stock Selection - Newser
How Pluri Inc. stock performs during market volatilityFree Stock Market Entry & Exit Signals - Newser
Why LMAT stock attracts strong analyst attentionFast Gains With Reduced Risk - Newser
Pluri Inc. shares rise 6.72% after-hours after announcing partnership with Forcepoint. - AInvest
Pluri (NASDAQ:PLUR) Trading Down 4% – What’s Next? - Defense World
Pluri Inc. director not re-elected, Nasdaq compliance cure period granted - Investing.com
PLUR SEC FilingsPluri Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Director Makes Major Investment in Pluri Stock! - TipRanks
Insiders Sold Pluri At US$5.87, Meanwhile Stock Sits Near US$4.30 - simplywall.st
Plurilock Security (CVE:PLUR) Stock Price Up 7.8% – Here’s What Happened - Defense World
Pluri (NASDAQ:PLUR) Now Covered by Alliance Global Partners - Defense World
Alliance Global Partners Initiates Coverage of Pluri (TASE:PLUR) with Buy Recommendation - Nasdaq
Alliance Global Partners Initiates Coverage of Pluri (PLUR) with Buy Recommendation - Nasdaq
Alliance Global Partners Initiates Coverage on Pluri (PLUR) with a "Buy" Rating | PLUR Stock News - GuruFocus
BCLI: Receives Regulatory Clearance to Initiate Phase 3b ALS Trial… - MSN
BrainStorm Secures Key Manufacturing Partnership with Minaris for Upcoming NurOwn® Phase 3b ALS Clinical Trials - The Malaysian Reserve
Pluri Inc. reschedules 2025 annual meeting By Investing.com - Investing.com South Africa
Pluri Inc Stock (PLUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.48%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):